Inventor · disambiguated record
Johannes Sam
Also filed as: SAM JOHANNES
7 granted patents·17 pending applications·27 citations·filing 2007–2025
81Inventor score
Top patents by PatentIndex Score
24 records- 0196US11718680B2Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonistsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 8, 2023·5 cites·32 claims
- 0292US11608376B2Tumor-targeted agonistic CD28 antigen binding moleculesHOFFMANN LA ROCHE·Filed 2019·Granted Mar 21, 2023·14 cites·49 claims
- 0382US11780919B2Bispecific antigen binding molecules targeting OX40 and FAPHOFFMANN LA ROCHE·Filed 2021·Granted Oct 10, 2023·1 cites·24 claims
- 0481US11192957B2Antibodies binding to HLA-A2/WT1HOFFMANN LA ROCHE·Filed 2018·Granted Dec 7, 2021·2 cites·38 claims
- 0581US10596257B2Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Mar 24, 2020·5 cites·52 claims
- 0681US2025129179A1Antibodies binding to hla-a2/wt1HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0775US12098213B2Antibodies binding to HLA-A2/WT1HOFFMANN LA ROCHE·Filed 2021·Granted Sep 24, 2024·0 cites·40 claims
- 0873US2024117049A1Bispecific antigen binding molecules targeting ox40 and fapHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0971US2024109976A1Combination therapy of anti-cd20/anti-cd3 bispecific antibodies and 4-1bb (cd137) agonistsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1069US2023355754A1Combination therapy of tumor targeted icos agonists with t-cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1166US12281153B2Combination therapy with targeted 4-1BB (CD137) agonistsHOFFMANN LA ROCHE·Filed 2020·Granted Apr 22, 2025·0 cites·24 claims
- 1265US2024368309A1Agonistic cd28 antigen binding molecules targeting epcamHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1364US2023416412A1Prevention or mitigation of t-cell engaging agent-related adverse effectsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1463US2025340614A1Combination therapy with targeted 4-1bb (cd137) agonistsHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1557US2020306373A1Combination therapy of tumor targeted icos agonists with t-cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1656US2022098305A1Novel icos antibodies and tumor-targeted antigen binding molecules comprising themHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1756US2024092856A1Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1855US2020376119A1Methods of treating cea-positive cancers using pd-1 axis binding antagonists and anti-cea/anti-cd3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1953US2021163617A1Therapeutic combination of 4-1 bb agonists with anti-cd20 antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2048US2020392237A1Combination therapy with targeted OX40 agonistsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2147US2020172627A1Type ii anti-cd20 antibody and anti-cd20/cd3 bispecific antibody for treatment of cancerHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2242US2025333530A1Combination treatment of glofitamab and chemotherapyHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2334US2012226119A1Vivo tumor vasculature imagingDOBOSZ MICHAEL·Filed 2010·Application pending·0 cites
- 2428US2010081699A1Yeast platform construction and screening methodsBIOALVO SERVICOS INVESTIGACAO·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Sam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →